At NCF Diagnostics & DNA Technologies (NCF DNA), our trademarked RespiraPath™ DNA test screens for various strains of the flu, sinus infections as well as streptococcus, which leads to many types of illnesses including pneumonia, ear infections, sinus infections and meningitis. In addition, we offer RespiraPath™ Immunocompromised that screens for viruses that specifically cause infection in the nose, sinuses and upper throat. RespiraPath™ STI screens for different strains for herpes including Varicella Zoser Virus, which causes chickenpox and shingles. Visit our website for more information about our lab screenings.

Unlike traditional laboratory tests that often produce false negatives and take weeks for results, NCF Diagnostics & DNA Technologies utilizes Real-Time PCR for pathogen identification, quantification and detection of antibiotic resistance. In addition, our revolutionary tests produce results within 24-48 hours of the patient sample arriving at our state-of-the-art facility. This helps doctors quickly diagnose and treat patients because we know that time lost is life loss.

Benefits include unnecessary testing reduces the spread of infection, identifies antibiotic resistance, and improves antibiotic stewardship, reduces misdiagnosis and unnecessary drug exposure.

We accept select commercial and federal insurance plans. Contact our billing department to determine if your health insurance will cover our advanced DNA tests.

Clinical Advantages

  • Detects All Polymicrobial Infections at Once
  • Provides an Accurate Diagnosis within 24 hours
  • Unaffected By Concurrent Antibiotic Use
  • Stops the Progression and Spread of Infection
  • Replaces Additional Unnecessary Diagnostic Testing
  • Decreases Healthcare Costs
  • Identifies Antibiotic Resistance
  • Improves Antibiotic Stewardship
  • Reduces Unnecessary Drug Exposure and Adverse Events
  • Decreases Patient Risks
  • Eliminates Subjectivity and Improves Clinical Confidence
  • Improves Patient Satisfaction